COVID in Context: The virus has a 1 in 56 death rate. The Johnson & Johnson vaccine has an unconfirmed 1 in 1,140,000 blood clot rate.

Published: Apr. 14, 2021 at 10:28 AM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

BRYAN, Texas (KBTX) - U.S. agencies the Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a “pause” in the administration of Johnson & Johnson’s COVID-19 vaccine after 6 cases of blood clots were discovered in 6.8 million doses distributed.

The blood clots are not confirmed to be linked to the J&J vaccine, but federal health officials say, out of an abundance of caution, they will investigate fully before recommending the vaccine’s use again.

Six cases out of 6.8 million doses translates to a .000088% rate of possibly linked blood clots, which also can be represented as one out of every 1.14 million doses given.

To compare, COVID-19 itself has a 1.8% death rate in the United States, or one out of every 56 confirmed cases has resulted in death.

Tune in for COVID in Context weekdays on Brazos Valley This Morning, 4:30-7 a.m. on KBTX.

Copyright 2021 KBTX. All rights reserved.